Abstract
Purpose: This report aims to assess the safety and feasibility of using an interdisciplinary rehabilitation intervention for a future randomized controlled trial in patients with gliomas in the initial treatment phase.
Method: We conducted an outpatient two-part rehabilitation intervention that involved six weeks of therapeutic supervised training (part one) and six weeks of unsupervised training in a local gym following a training protocol (part two).
Results: Predefined feasibility objectives of safety (100%), consent rate (>80%), drop-out (<20%), adherence (>80%) and patient satisfaction (>80%) was achieved at part one. However, the failure to meet predefined feasibility objectives of drop-out, adherence and patient satisfaction of the unsupervised intervention at part two have led to a protocol revision for a future randomized controlled trial.
Conclusion: This study demonstrates that an intensive rehabilitation intervention of physical therapy and occupational therapy in the initial treatment phase of patients with gliomas whose Karnofsky performance status is ≥70 is safe and feasible, if relevant inclusion criteria and precautionary screening are made. With the revised protocol, we are confident that the foundation for conducting a successful randomized controlled trial among these vulnerable patients has been established.
Brain tumors constitute some of the most challenging cancer diagnoses presenting for rehabilitation intervention.
Patients with gliomas experiences limitations in physical functioning, cognition, and emotional wellbeing.
In a relatively small sample this study shows that supervised physical- and occupational therapy in patients with gliomas is safe and feasible in the initial treatment phase.
Patients with gliomas can potentially improve functioning through interdisciplinary rehabilitation
Implications for rehabilitation
Acknowledgements
The authors acknowledge PT: Cathrine Toft Lundgaard, Bolette Madsen, Kathrine Juul Jensen and OT: Anne Lykkehøj Bystrup, Trine Engdal Poulsen for guiding the patient through the therapeutic interventions. They also thank specialist nurse: Camilla Nellemann Larsen for managing the patient and neurooncologist Dagmar Beier for consulting.
Disclosure statement
The authors report no conflict of interest. The study does not receive external funding and the authors alone are responsible for the content and writing of this paper.